Principal Financial Group’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Principal Financial Group’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-452,683	Closed	-$15.9M	–	2274
2014 Q3	$15.9M	Sell	452,683 -164,391	-27%	-$5.63M	0.03%	624
2014 Q2	$20.3M	Sell	617,074 -1,016,838	-62%	-$34.8M	0.03%	518
2014 Q1	$60.2M	Buy	1,633,912 +648,013	+66%	+$23.8M	0.11%	239
2013 Q4	$37.8M	Buy	985,899 +270,209	+38%	+$8.53M	0.07%	321
2013 Q3	$19.6M	Sell	715,690 -12,073	-2%	-$286K	0.04%	463
2013 Q2	$15.3M	Buy	+727,763	New	+$14.2M	0.03%	542

Other funds holding WX

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Principal Financial Group's WX Position: Q4 2014 in Review

Principal Financial Group sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2014, closing a stake of 452,683 shares — an estimated $15.9M sold.

Principal Financial Group first reported a position in WX in Q2 2013 and held it in 6 quarters. The position peaked at $60.2M in Q1 2014. 165 funds tracked by Wall St. Rank hold WX as of Q4 2014.

Principal Financial Group reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2014 after selling out during the quarter.
Principal Financial Group sold 452,683 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2014, an estimated $15.9M.
Principal Financial Group first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 6 quarters.
Principal Financial Group's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $60.2M in Q1 2014.
165 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2014.

Based on Principal Financial Group's 13F filing for Q4 2014, filed 12 Feb 2015.